CME Group Inc. (NASDAQ:CME) Position Trimmed by First PREMIER Bank

First PREMIER Bank cut its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 3.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,906 shares of the financial services provider’s stock after selling 63 shares during the period. First PREMIER Bank’s holdings in CME Group were worth $442,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of CME. Franklin Resources Inc. lifted its position in CME Group by 70.4% in the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock valued at $544,157,000 after purchasing an additional 1,003,119 shares during the last quarter. Ameriprise Financial Inc. grew its position in CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares in the last quarter. International Assets Investment Management LLC increased its position in shares of CME Group by 21,465.5% during the 3rd quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock valued at $1,072,070,000 after purchasing an additional 483,618 shares during the period. Canoe Financial LP lifted its holdings in shares of CME Group by 698.0% in the fourth quarter. Canoe Financial LP now owns 544,219 shares of the financial services provider’s stock valued at $126,384,000 after buying an additional 476,019 shares during the period. Finally, Janus Henderson Group PLC boosted its stake in CME Group by 17.8% during the third quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after buying an additional 380,071 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Bank of America raised their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Piper Sandler raised their target price on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a research report on Monday, January 6th. Morgan Stanley lifted their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Finally, Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $229.27.

View Our Latest Report on CME

Insider Activity at CME Group

In related news, insider Sunil Cutinho sold 4,500 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the sale, the insider now owns 27,053 shares in the company, valued at $6,131,291.92. This represents a 14.26 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now owns 7,275 shares in the company, valued at approximately $1,652,298. This represents a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 7,274 shares of company stock worth $1,648,071. 0.30% of the stock is owned by insiders.

CME Group Trading Up 0.1 %

CME stock opened at $232.53 on Thursday. The business has a fifty day moving average of $233.64 and a 200-day moving average of $220.69. The company has a market cap of $83.79 billion, a P/E ratio of 24.45, a PEG ratio of 5.27 and a beta of 0.56. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $249.02. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the company posted $2.25 EPS. The company’s revenue was up 18.4% compared to the same quarter last year. As a group, equities research analysts expect that CME Group Inc. will post 10.18 EPS for the current year.

CME Group Increases Dividend

The business also recently declared a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were given a $5.80 dividend. This is a positive change from CME Group’s previous dividend of $2.50. The ex-dividend date was Friday, December 27th. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

CME Group announced that its board has initiated a share buyback plan on Thursday, December 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.